These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3534700)

  • 1. [Pharmacokinetics of ceftazidime injected peritoneally in continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Vergnaud M; Hurault de Ligny B; Allouche G; Malbruny B; Morel C
    Pathol Biol (Paris); 1986 May; 34(5):328-31. PubMed ID: 3534700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
    Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
    Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of peritonitis under continuous ambulatory peritoneal dialysis using intraperitoneal ceftazidime].
    Ragnaud JM; Dupon M; Morlat P; Bezian MC; Wone C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):681-4. PubMed ID: 2677930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gray HH; Goulding S; Eykyn SJ
    Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
    Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
    Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125.
    Manley HJ; Elwell RJ; Bailie GR; Welch CL
    Ann Pharmacother; 2004 Dec; 38(12):2035-40. PubMed ID: 15536141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
    Pasadakis P; Thodis E; Eftimimiadou A; Panagoutsos S; Papazoglou D; Kaliengidou M; Kartali S; Vargemezis V
    Adv Perit Dial; 1993; 9():206-10. PubMed ID: 8105925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
    Montañés Pauls B; Almiñana MA; Casabó Alós VG
    Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
    Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L
    Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysis.
    Cardone KE; Grabe DW; Zasowski EJ; Lodise TP
    Antimicrob Agents Chemother; 2014; 58(1):19-26. PubMed ID: 24126585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
    Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The latest trends in the treatment peritonitis of the patients on peritoneal dialysis].
    Hájková B; Fixa P
    Vnitr Lek; 2004 Aug; 50(8):619-23. PubMed ID: 15521206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of peritonitis due to continuous ambulatory peritoneal dialysis using a single daily intraperitoneal dose of 1g cefotiam].
    Ragnaud JM; Roche-Bezian MC; Marceau C; Demothes-Mainard F; Albin H; Prevost D; Wone C
    Pathol Biol (Paris); 1986 May; 34(5):512-6. PubMed ID: 3534734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
    Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
    Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis.
    Demotes-Mainard F; Vinçon G; Ragnaud JM; Morlat P; Bannwarth B; Dangoumau J
    J Clin Pharmacol; 1993 May; 33(5):475-9. PubMed ID: 8331207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.